Christopher A. Eide

Functional genomic landscape of acute myeloid leukaemia

Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly et al. · Nature · 2018 · 1.5K citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

Thomas O’Hare, William C. Shakespeare, Xiaotian Zhu et al. · Cancer Cell · 2009 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +9

Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia

Thomas O’Hare, Christopher A. Eide, Michael W. Deininger · Blood · 2007 · 640 citations · Full text

Medicine, Cancer Biology, Oncology +16

Oncogenic<i>CSF3R</i>Mutations in Chronic Neutrophilic Leukemia and Atypical CML

Julia E. Maxson, Jason Gotlib, Daniel A. Pollyea et al. · New England Journal of Medicine · 2013 · 563 citations · Full text

Medicine, Hematology, Oncology +17

Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinations

Heather A. Bradeen, Christopher A. Eide, Thomas O’Hare et al. · Blood · 2006 · 401 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +8